Shares of Biophytis S.A. (NASDAQ:BPTS – Get Rating) are set to reverse split on the morning of Thursday, March 30th. The 1-10 reverse split was announced on Thursday, March 30th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, March 30th.
Biophytis Stock Performance
Biophytis stock traded down $0.07 during midday trading on Friday, reaching $0.48. The stock had a trading volume of 112,717 shares, compared to its average volume of 980,509. Biophytis has a 12 month low of $0.35 and a 12 month high of $3.36. The company has a fifty day moving average price of $0.49 and a two-hundred day moving average price of $0.54.
Analysts Set New Price Targets
Separately, HC Wainwright reiterated a “buy” rating and set a $15.00 price target on shares of Biophytis in a research note on Monday, February 27th.
Biophytis Company Profile
Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases.
- Get a free copy of the StockNews.com research report on Biophytis (BPTS)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Biophytis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biophytis and related companies with MarketBeat.com's FREE daily email newsletter.